American International Group’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-237,773
Closed -$9.67M 1152
2024
Q1
$9.67M Sell
237,773
-4,125
-2% -$155K 0.03% 436
2023
Q4
$8.94M Sell
241,898
-7,662
-3% -$289K 0.04% 452
2023
Q3
$9.53M Sell
249,560
-12,160
-5% -$498K 0.06% 373
2023
Q2
$9.44M Sell
261,720
-9,834
-4% -$336K 0.06% 425
2023
Q1
$10.4M Sell
271,554
-646
-0.2% -$30.3K 0.07% 354
2022
Q4
$15.5M Sell
272,200
-8,210
-3% -$420K 0.11% 164
2022
Q3
$11.1M Sell
280,410
-9,587
-3% -$424K 0.08% 273
2022
Q2
$12.8M Sell
289,997
-15,772
-5% -$682K 0.09% 218
2022
Q1
$12.2M Sell
305,769
-4,389
-1% -$156K 0.07% 346
2021
Q4
$12.5M Sell
310,158
-10,528
-3% -$393K 0.06% 367
2021
Q3
$13M Buy
320,686
+5,622
+2% +$235K 0.07% 319
2021
Q2
$14.3K Buy
315,064
+2,386
+0.8% +$106K 0.05% 343
2021
Q1
$13K Buy
312,678
+654
+0.2% +$29.9K 0.05% 373
2020
Q4
$13.3K Buy
312,024
+230,808
+284% +$8.3M 0.05% 322
2020
Q3
$2.13M Sell
81,216
-1,846
-2% -$51.4K 0.01% 940
2020
Q2
$2.23M Buy
83,062
+3,450
+4% +$77.8K 0.01% 927
2020
Q1
$1.43M Sell
79,612
-10,025
-11% -$190K 0.01% 979
2019
Q4
$1.59M Sell
89,637
-755
-0.8% -$13.1K 0.01% 1102
2019
Q3
$1.4M Sell
90,392
-630
-0.7% -$10.4K 0.01% 1132
2019
Q2
$1.56M Buy
91,022
+11,452
+14% +$185K 0.01% 1105
2019
Q1
$1.28M Sell
79,570
-2,579
-3% -$41.8K ﹤0.01% 1189
2018
Q4
$1.2M Sell
82,149
-632
-0.8% -$10.1K ﹤0.01% 1175
2018
Q3
$1.5M Buy
82,781
+1,492
+2% +$26.1K 0.01% 1193
2018
Q2
$1.37M Buy
81,289
+5,001
+7% +$94.6K ﹤0.01% 1197
2018
Q1
$1.49M Sell
76,288
-4,101
-5% -$79.4K 0.01% 1074
2017
Q4
$1.63M Buy
80,389
+1,179
+1% +$21.7K 0.01% 1100
2017
Q3
$1.38M Buy
79,210
+11,482
+17% +$156K ﹤0.01% 1161
2017
Q2
$868K Buy
67,728
+619
+0.9% +$8.27K ﹤0.01% 1371
2017
Q1
$870K Buy
67,109
+4,407
+7% +$55.7K ﹤0.01% 1275
2016
Q4
$619K Sell
62,702
-162
-0.3% -$1.77K ﹤0.01% 1518
2016
Q3
$759K Buy
62,864
+96
+0.2% +$981 ﹤0.01% 1372
2016
Q2
$542K Sell
62,768
-404
-0.6% -$3.99K ﹤0.01% 1540
2016
Q1
$598K Sell
63,172
-430
-0.7% -$4.05K ﹤0.01% 1865
2015
Q4
$1.1M Sell
63,602
-408
-0.6% -$6.5K ﹤0.01% 1442
2015
Q3
$860K Sell
64,010
-1,002
-2% -$20.1K ﹤0.01% 1571
2015
Q2
$1.47M Sell
65,012
-2,829
-4% -$49.7K 0.01% 1320
2015
Q1
$969K Buy
67,841
+1,740
+3% +$25.1K ﹤0.01% 1635
2014
Q4
$638K Sell
66,101
-2,573
-4% -$22.9K ﹤0.01% 1925
2014
Q3
$625K Sell
68,674
-50
-0.1% -$476 ﹤0.01% 1941
2014
Q2
$679K Buy
68,724
+2,422
+4% +$20.5K ﹤0.01% 1911
2014
Q1
$842K Buy
66,302
+7,260
+12% +$108K ﹤0.01% 1671
2013
Q4
$885K Sell
59,042
-1,092
-2% -$14K ﹤0.01% 1558
2013
Q3
$664K Sell
60,134
-2,252
-4% -$18.8K ﹤0.01% 1740
2013
Q2
$495K Buy
+62,386
New +$397K ﹤0.01% 1862

Other funds holding HALO

American International Group's HALO Position: Q2 2024 in Review

American International Group sold out of Halozyme (HALO) in Q2 2024, closing a stake of 237,773 shares — an estimated $9.67M sold.

American International Group first reported a position in HALO in Q2 2013 and held it in 44 quarters. The position peaked at $15.5M in Q4 2022. 460 funds tracked by Wall St. Rank hold HALO as of Q2 2024.

  • American International Group reported no remaining Halozyme position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 237,773 Halozyme shares in Q2 2024, an estimated $9.67M.
  • American International Group first reported a position in Halozyme in Q2 2013 and held it in 44 quarters.
  • American International Group's Halozyme position peaked at $15.5M in Q4 2022.
  • 460 funds tracked by Wall St. Rank held Halozyme as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.